Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia Leukemia
). The miRs are 17-25 bp, generated from longer noncoding RNAs in step-wise processes. First, primary miRs are transcribed from genomic DNA and then truncated to produce B70 bp of RNAs, called precursor miRs in the nucleus. Second, the precursor miRs are further cut to become mature miRs in the cytoplasm. Although the detailed mechanism remains unclear, the miRs can function as translation repressors through binding to 3 0 untranslation regions of target messenger RNAs. Since many miRs highly conserve nucleotide alignments between distantly related species, it has been suggested that the small RNAs have fundamental biological roles. Accumulated results have proven that miRs participate in diverse biological processes. Examples include developmental timing, cellular Capital, small-bold and small-plain letters represent the IGH, the 11q24 and the unknown origin sequences, respectively. The precursor miR-125b-1 sequence is underlined and the miR-125b sequence (tccctgagaccctaacttgtga) is in box. (c) A 127 bp of DNA fragment of the insertion point was amplified by nested PCR using CTACAACCCGTCCCTCAAGA and TCACCACCACAATATCTAGGC for the first-round PCR and CCAGTTCTCCCT GAAGCTGA and ACTGAGAGGAGCGCAACAAT for the second round. As a positive control, a 393 bp of germline C-MYC gene was amplified using GGTGTTAGGACGTGGTGTTGGGTA and GAGGTGGCGGTGAGGAAAACAATTT for the first-round PCR and GGTAGGCGCAGG CAGGGGAAAA and CCAACACTCCTTTTGCCAGCTTTC for the second-round PCR. All PCR products were sequenced. M: DNA size marker (f174/HaeIII). asymmetry, cell growth, apoptosis and hematopoiesis. 1, 2 In addition to the biological roles of miRs, a number of miRs have been found to associate with chromosome amplification, deletion and translocation sites seen in B-cell malignancies, suggesting involvements of miRs in the tumorigenesis. 3, 4 In fact, a very recent report has demonstrated that an miRNA polycistron (miR-17-19b) on chromosome 13 band q31-32 can act as oncogenes. 5 The immunoglobulin heavy chain (IGH) gene is a common target of genetic alteration in B-cell malignancies. 6 The genetic alteration includes reciprocal translocation between the IGH's and other gene's loci, transposition of genes into the IGH locus and insertion of IGH segment into other chromosome loci. 6 The affected genes show deregulated expression leading B cell to uncontrolled proliferation through several pathways. Here, we report an unusual IGH rearrangement exhibiting insertion of miR-125b-1 sequence, seen in a patient with precursor B-ALL.
A 35-year-old woman had a diagnosis of leukemic recurrence as bilateral ovarian tumors 7 years after allogeneic bone marrow transplantation. 7 The ovarian tumor was histologically consistent of lymphoblastic lymphoma with immunophenotypically positive for TdT, CD10 and CD19. Southern blot analyses of the tumor cells demonstrated a single rearranged joining segment of the IGH gene (IGHJ) with a faint germline band, suggesting deletion of another IGHJ allele (Figure 1a) . A 4.2 kb rearranged band detected by Southern blot after PstI digest was amplified as a 1.8 kb product by long-distance inverse PCR (LDI-PCR) 8 and sequenced (Figure 1a) . The sequence and database (BLAST search program; www.ncbi.nlm.nih.gov/BLAST) analyses revealed that a 213 bp DNA fragment derived from chromosome 11q24 with 42 bp nucleotides of unknown origin had been inserted into the rearranged IGH allele (Figure 1b) . We confirmed the fidelity of the LDI-PCR results by comigration studies using a unique sequence of the inserted DNA fragment (Figure 1a) . Intriguingly, the 11q24-derived sequence contained both precursor (88 bp) and mature (22 bp) sequences of miR-125b-1 indicating that the IGH rearrangement resulted in the excision of miR from the germline locus. The expression of the miR in the tumor cells has not been examined due to limitation of the material.
We then asked whether the insertion was an initial or secondary event during relapse as ovarian tumor cells. DNA was isolated from a bone marrow smear at initial diagnosis and subjected to nested PCR using IGH-and 11q24-specific primer pairs. The nested PCR yielded the same PCR product from leukemic cells at initial diagnosis as well as from relapsing ovarian tumor cells (Figure 1c ). This result suggested that the miR insertion into the IGH locus possibly involved an early step in leukemogenesis.
Three miR-125s (miR-125a, miR-125b-1 and miR-125b-2) are thought to be homologues of Caenorhabditis elegans lin-4 miRNA. 4 The miR-125a and miR-125b differ only by a central di-uridine insertion, a uridine to cytosine change, and an adenine addition. The miR-125b-1 and miR-125b-2 are the same sequence, but originated from independent precursors located on different chromosome loci. Interestingly, previous studies have reported that C. elegans lin-4 regulates the timing of larval development 2 and that Drosophila melanogaster miR-125b expression is detectable in only adult stage, not in egg. 4 These results suggest that the miR-125s involve in the timing of tissue development or cell differentiation. The insertion of miR-125b-1 into the IGH allele might impair the expression of the small RNA in precursor B cell leading to aberrant differentiation.
In conclusion, our patient is the first example to show that miR-125b-1 might imply in the leukemogenesis of the precursor B-ALL cells and is a target gene of IGH alteration.
